[Form 4] Gen Digital Inc. Insider Trading Activity
Gen Digital director Nora Denzel received an annual non-employee director equity award of 8,822 restricted stock units (RSUs) on 09/09/2025 at a reported price of $0. Following the grant, Ms. Denzel beneficially owns 43,682 shares of Gen Digital common stock. The RSUs vest 100% on the earlier of September 9, 2026 or the company’s next annual meeting, subject to continued service through the vesting date. The Form 4 was signed by an attorney-in-fact on 09/10/2025.
- Director-shareholder alignment via an annual RSU award that ties compensation to long-term equity value
- Clear vesting schedule: 100% vesting on the earlier of 09/09/2026 or the next annual meeting, providing predictable service-based vesting
- Potential dilution from issuance of 8,822 RSUs, magnitude cannot be assessed without total shares outstanding
- No materiality context provided (e.g., percentage of outstanding shares), limiting assessment of investor impact
Insights
TL;DR: Routine annual director equity grant that aligns director incentives with shareholders without indicating material change.
The grant is described as the issuer’s standard annual non-employee director award and vests based on service through the earlier of one year or the next annual meeting. This structure is common practice to align outside directors with shareholder interests. The transaction increases Ms. Denzel’s beneficial ownership to 43,682 shares after the award. There is no exercise price because these are RSUs rather than options, and no additional governance actions or unusual vesting conditions are disclosed. Impact on shareholder dilution appears immaterial from the data provided but cannot be fully assessed without total outstanding share count.
TL;DR: The filing documents a routine, compensatory equity award and proper Section 16 reporting.
The Form 4 reports an annual compensation-related grant to a director, using transaction code 'A' (acquisition) and discloses the vesting schedule and beneficial ownership after the grant. The Form is executed by an attorney-in-fact and includes the necessary details: transaction date, number of RSUs, $0 price indication consistent with RSU grants, and vesting terms. From a compliance perspective the filing appears complete for this single transaction; no amendments or further disclosures are present.